By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Contact Information

Website: www.astrazeneca.com
Email: ir@astrazeneca.com
Main Phone: +44 2037495000
Address: 1 Francis Crick Avenue
Address 2: Cambridge Biomedical Campus
City / Town: Cambridge
Country: GB
Postal Code: CB2 0AA

Issuer Information

Exchange: NGS
CEO: Pascal Soriot
Employees: 76100
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A